The resolution calls for an additional $50 million from the family and acceleration of some milestone payments, according to the mediation document. In all, the contribution from the Sacklers will be about $4.5 billion over nine years. Purdue Pharma, which has not actively marketed OxyContin for two years, will be wound down or sold by 2024.
The states did win a concession that a trove of 30 million documents relating to Purdue Pharma and the Sackler familys marketing of OxyContin would be made public. The family, whose naming rights for museums and art exhibits have attracted protests, also will not be allowed to place its brand on future charitable gifts until terms of the dea…
Read the full article at: https://www.washingtonpost.com/business/2021/07/08/purdue-sackler-bankruptcy-settlement/